Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2015, Article ID 828646, 9 pages
http://dx.doi.org/10.1155/2015/828646
Research Article

Polymorphisms of Homologous Recombination RAD51, RAD51B, XRCC2, and XRCC3 Genes and the Risk of Prostate Cancer

1Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland
2Department of Biophysics of Environmental Pollution, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland
3Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland
42nd Department of Urology, Faculty of Biomedical Sciences and Postgraduate Training, Medical University of Lodz, 93-513 Lodz, Poland

Received 29 April 2015; Revised 10 July 2015; Accepted 15 July 2015

Academic Editor: Francesco A. Mauri

Copyright © 2015 Maria Nowacka-Zawisza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Wojciechowska, J. Didkowska, and W. Zatoński, Cancer in Poland in 2012, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Polish National Cancer Registry, Warsaw, Poland, 2014.
  2. National Collaborating Centre for Cancer, Prostate Cancer: Diagnosis and Treatment, National Institute for Health and Care Excellence (NICE), London, UK, 2014.
  3. Y. Kitagishi, M. Kobayashi, and S. Matsuda, “Defective DNA repair systems and the development of breast and prostate cancer,” International Journal of Oncology, vol. 42, no. 1, pp. 29–34, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Serra, O. Da Ines, F. Degroote, M. E. Gallego, and C. I. White, “Roles of XRCC2, RAD51B and RAD51D in RAD51-independent SSA recombination,” PLoS Genetics, vol. 9, no. 11, Article ID e1003971, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Chun, E. S. Buechelmaier, and S. N. Powell, “Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway,” Molecular and Cellular Biology, vol. 33, no. 2, pp. 387–395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Paulíková, M. Chmelařová, J. Petera, V. Palička, and A. Paulík, “Hypermethylation of RAD51L3 and XRCC2 genes to predict late toxicity in chemoradiotherapy-treated cervical cancer patients,” Folia Biologica, vol. 59, no. 6, pp. 240–245, 2013. View at Google Scholar · View at Scopus
  7. S. Shi, L. Qin, M. Tian et al., “The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis,” Tumor Biology, vol. 35, no. 6, pp. 5797–5804, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Cheng, H. Shi, K. Zhang, L. Yi, and G. Zhen, “RAD51 gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis,” Diagnostic Pathology, vol. 9, article 18, 2014. View at Publisher · View at Google Scholar
  9. R. Krupa, T. Sliwinski, M. Wisniewska-Jarosinska et al., “Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer—a case control study,” Molecular Biology Reports, vol. 38, no. 4, pp. 2849–2854, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Miao, X. F. Qian, G. H. Yang, and L. D. Zhao, “Relationship between RAD51-G135C and XRCC3-C241T single nucleotide polymorphisms and onset of acute myeloid leukemia,” Journal of Experimental Hematology, vol. 23, no. 3, pp. 605–611, 2015. View at Google Scholar
  11. Z. Qureshi, I. Mahjabeen, R. M. Baig, and M. A. Kayani, “Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 23, pp. 10225–10229, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Esfahani, N. Ataei, and M. Panjehpour, “Biomarkers for evaluation of prostate cancer prognosis,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 7, pp. 2601–2611, 2015. View at Google Scholar
  13. L. R. Ferguson, H. Chen H, A. R. Collins et al., “Genomic instability in human cancer: molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition,” Seminars in Cancer Biology, 2015. View at Publisher · View at Google Scholar
  14. L. Krejci, V. Altmannova, M. Spirek, and X. Zhao, “Homologous recombination and its regulation,” Nucleic Acids Research, vol. 40, no. 13, pp. 5795–5818, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. San Filippo, P. Sung, and H. Klein, “Mechanism of eukaryotic homologous recombination,” Annual Review of Biochemistry, vol. 77, pp. 229–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. S. Walsh, “Two decades beyond BRCA1/2: homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy,” Gynecologic Oncology, vol. 137, no. 2, pp. 343–350, 2015. View at Publisher · View at Google Scholar
  17. A. C. Antoniou, O. M. Sinilnikova, J. Simard et al., “RAD51 135G→C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies,” The American Journal of Human Genetics, vol. 81, no. 6, pp. 1186–1200, 2007. View at Google Scholar
  18. L. Hasselbach, S. Haase, D. Fischer, H.-C. Kolberg, and H.-W. Stürzbecher, “Characterisation of the promoter region of the human DNA-repair gene Rad51,” European Journal of Gynaecological Oncology, vol. 26, no. 6, pp. 589–598, 2005. View at Google Scholar · View at Scopus
  19. D. Chekravarti, V. J. LaMorte, M. C. Nelson et al., “Role of CBP/P300 in nuclear receptor signalling,” Nature, vol. 383, no. 6595, pp. 99–103, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Romanowicz-Makowska, B. Smolarz, M. Zadrozny et al., “The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland,” European Journal of Gynaecological Oncology, vol. 33, no. 2, pp. 145–150, 2012. View at Google Scholar · View at Scopus
  21. H. Sun, J. Bai, F. Chen et al., “RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects,” Breast Cancer Research and Treatment, vol. 125, no. 1, pp. 157–161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. B.-B. Zhang, D.-G. Wang, C. Xuan, G.-L. Sun, and K.-F. Deng, “Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls,” Familial Cancer, vol. 13, no. 4, pp. 515–526, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Smolarz, M. Zadrozny, J. Duda-Szymańska et al., “RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women,” Polish Journal of Pathology, vol. 64, no. 1, pp. 39–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Romanowicz-Makowska, B. Smolarz, D. Samulak et al., “A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and ovarian cancer risk in Polish women,” European Journal of Gynaecological Oncology, vol. 33, no. 4, pp. 406–410, 2012. View at Google Scholar · View at Scopus
  25. B. Smolarz, M. Makowska, D. Samulak et al., “Association between polymorphisms of the DNA repair gene RAD51 and ovarian cancer,” Polish Journal of Pathology, vol. 64, no. 4, pp. 290–295, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Krupa, A. Sobczuk, T. Popławski, K. Wozniak, and J. Blasiak, “DNA damage and repair in endometrial cancer in correlation with the hOGG1 and RAD51 genes polymorphism,” Molecular Biology Reports, vol. 38, no. 2, pp. 1163–1170, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. M. Michalska, D. Samulak, H. Romanowicz, and B. Smolarz, “Association of polymorphisms in the 5′ untranslated region of RAD51 gene with risk of endometrial cancer in the Polish population,” Archives of Gynecology and Obstetrics, vol. 290, no. 5, pp. 985–991, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Smolarz, D. Samulak, M. Michalska et al., “135G>C and 172G>T polymorphism in the 5′ untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women,” Polish Journal of Pathology, vol. 62, no. 3, pp. 157–162, 2011. View at Google Scholar · View at Scopus
  29. S. Nissar, S. M. Baba, T. Akhtar, R. Rasool, Z. A. Shah, and A. S. Sameer, “RAD51 G135C gene polymorphism and risk of colorectal cancer in Kashmir,” European Journal of Cancer Prevention, vol. 23, no. 4, pp. 264–268, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Romanowicz-Makowska, D. Samulak, M. Michalska et al., “RAD51 gene polymorphisms and sporadic colorectal cancer risk in Poland,” Polish Journal of Pathology, vol. 63, no. 3, pp. 193–198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Popławski, M. Arabski, D. Kozirowska et al., “DNA damage and repair in gastric cancer—a correlation with the hOGG1 and RAD51 genes polymorphisms,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 601, no. 1-2, pp. 83–91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Kayani, S. Khan, R. M. Baig, and I. Mahjabeen, “Association of RAD51 135 G/C, 172 G/T and XRCC3 Thr241Met gene polymorphisms with increased risk of head and neck cancer,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 23, pp. 10457–10462, 2014. View at Google Scholar
  33. T. Śliwiński, A. Walczak, K. Przybyłowska et al., “Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and risk of a head and neck cancer in a Polish population,” Experimental and Molecular Pathology, vol. 89, no. 3, pp. 358–366, 2010. View at Google Scholar
  34. Y.-Z. He, X. Hu, X.-S. Chi et al., “Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: evidence based on a meta-analysis,” Tumor Biology, vol. 35, no. 1, pp. 615–621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Synowiec, K. A. Wojcik, J. Izdebska et al., “Polymorphisms of the homologous recombination gene RAD51 in keratoconus and fuchs endothelial corneal dystrophy,” Disease Markers, vol. 35, no. 5, pp. 353–362, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Kadouri, Z. Kote-Jarai, A. Hubert et al., “A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers,” British Journal of Cancer, vol. 90, no. 10, pp. 2002–2005, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Levy-Lahad, A. Lahad, S. Eisenberg et al., “A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3232–3236, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Synowiec, J. Stefańska, Z. Morawiec, J. Blasiak, and K. Wozniak, “Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients,” Mutation Research, vol. 648, no. 1-2, pp. 65–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Wang, J.-L. Li, X.-F. He et al., “Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls,” PLoS ONE, vol. 8, no. 9, Article ID e75153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. W. W. Wang, A. B. Spurdle, P. Kolachana et al., “A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers,” Cancer Epidemiology, Biomarkers & Prevention, vol. 10, no. 9, pp. 955–960, 2001. View at Google Scholar · View at Scopus
  41. H. L. Ribeiro Junior, R. T. de Oliveira, A. R. Maia et al., “Polymorphisms of DNA repair genes are related to the pathogenesis of myelodysplastic syndrome,” Hematological Oncology, 2014. View at Publisher · View at Google Scholar
  42. A. Auranen, H. Song, C. Waterfall et al., “Polymorphisms in DNA repair genes and epithelial ovarian cancer risk,” International Journal of Cancer, vol. 117, no. 4, pp. 611–618, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Kuschel, A. Auranen, S. McBride et al., “Variants in DNA double-strand break repair genes and breast cancer susceptibility,” Human Molecular Genetics, vol. 11, no. 12, pp. 1399–1407, 2002. View at Publisher · View at Google Scholar
  44. K.-M. Lee, J.-Y. Choi, C. Kang et al., “Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk,” Clinical Cancer Research, vol. 11, no. 12, pp. 4620–4626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. M. M. Michalska, D. Samulak, H. Romanowicz, and B. Smolarz, “Single nucleotide polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T homologous recombination repair genes and the risk of triple- negative breast cancer in Polish women,” Pathology & Oncology Research, 2015. View at Publisher · View at Google Scholar
  46. S. Rollinson, A. G. Smith, J. M. Allan et al., “RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia,” Leukemia Research, vol. 31, no. 2, pp. 169–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. K. A. W. Wadt, L. G. Aoude, L. Golmard et al., “Germline RAD51B truncating mutation in a family with cutaneous melanoma,” Familial Cancer, vol. 14, no. 2, pp. 337–340, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. X. O. Shu, J. Long, W. Lu et al., “Novel genetic markers of breast cancer survival identified by a genome-wide association study,” Cancer Research, vol. 72, no. 5, pp. 1182–1189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. J. D. Figueroa, M. Garcia-Closas, M. Humphreys et al., “Associations of common variants at 1p11.2 and 14q24.1 (RAD51l1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium,” Human Molecular Genetics, vol. 20, no. 23, Article ID ddr368, pp. 4693–4706, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Zhou, D. Wang, J. Zhang et al., “RAD51 gene is associated with advanced age-related macular degeneration in Chinese population,” Clinical Biochemistry, vol. 46, no. 16-17, pp. 1689–1693, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Bashir, S. Sana, I. Mahjabeen, and M. A. Kayani, “Association of reduced XRCC2 expression with lymph node metastasis in breast cancer tissues,” Familial Cancer, vol. 13, no. 4, pp. 611–617, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Z. Song, F. J. Han, M. Liu et al., “Association between single nucleotide polymorphisms in XRCC3 and radiation-induced adverse effects on normal tissue: a meta-analysis,” PLoS ONE, vol. 10, no. 6, Article ID e0130388, 2015. View at Publisher · View at Google Scholar
  53. K.-D. Yu, A.-X. Chen, L.-X. Qiu, L. Fan, C. Yang, and Z.-M. Shao, “XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects,” Breast Cancer Research and Treatment, vol. 123, no. 1, pp. 219–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. S. N. Silva, M. Tomar, C. Paulo et al., “Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51,” Cancer Epidemiology, vol. 34, no. 1, pp. 85–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Smolarz, M. Makowska, D. Samulak et al., “Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women,” Clinical and Experimental Medicine, vol. 15, no. 2, pp. 151–157, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. L. O. Pérez, A. Crivaro, G. Barbisan, L. Poleri, and C. D. Golijow, “XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk,” Pathology & Oncology Research, vol. 19, no. 3, pp. 553–558, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Curtin, W.-Y. Lin, R. George et al., “Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 9, pp. 2476–2484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. R. J. Hung, D. C. Christiani, A. Risch et al., “International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways,” Cancer Epidemiology, Biomarkers and Prevention, vol. 17, no. 11, pp. 3081–3089, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. S. G. Reeves, C. Meldrum, C. Groombridge et al., “DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome,” Cancer Epidemiology, vol. 36, no. 2, pp. 183–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Costa, D. Pinto, D. Pereira et al., “DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population,” Breast Cancer Research and Treatment, vol. 103, no. 2, pp. 209–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. H.-C. Luo, H.-B. Zhang, X.-J. Xin, and W.-X. Huang, “Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population,” Tumor Biology, vol. 35, no. 4, pp. 3415–3419, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. Q. Ma, Y. Zhao, S. Wang et al., “Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies,” Tumor Biology, vol. 35, no. 2, pp. 1473–1480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Ding, Y. Yang, L. Cheng et al., “The relationship between seven common polymorphisms from five DNA repair genes and the risk for breast cancer in northern Chinese women,” PLoS ONE, vol. 9, no. 3, Article ID e92083, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. R. J. Hung, D. C. Christiani, A. Risch et al., “International lung cancer consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 11, pp. 3081–3089, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. V. Margulis, J. Lin, H. Yang, W. Wang, C. G. Wood, and X. Wu, “Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 9, pp. 2366–2373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. C. L. Pearce, A. M. Near, D. J. van den Berg et al., “Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium,” British Journal of Cancer, vol. 100, no. 2, pp. 412–420, 2009. View at Publisher · View at Google Scholar
  67. L. O. Pérez, A. Crivaro, G. Barbisan, L. Poleri, and C. D. Golijow, “XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk,” Pathology and Oncology Research, vol. 19, no. 3, pp. 553–558, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Yan, H. Liang, T. Li et al., “Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis,” Leukemia and Lymphoma, vol. 55, no. 9, pp. 2130–2134, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. V. S. Dhillon, M. Phil, E. Yeoh, and M. Fenech, “DNA repair gene polymorphisms and prostate cancer risk in South Australia—results of a pilot study,” Urologic Oncology: Seminars and Original Investigations, vol. 29, no. 6, pp. 641–646, 2011. View at Publisher · View at Google Scholar · View at Scopus